ORMP Oramed Pharmaceuticals Inc. - Common Stock
$4.83
Price · Aug 19, 2026
Fundamentals as of Aug 10, 2026
52W Range
$2–$5
89% of range
Analyst Rating
HOLD
6 analysts
Price Target
$6
+29% upside
P/E (TTM)
0.0
ROE
37.0%
Net Profit Margin
3202.5%
About Oramed Pharmaceuticals Inc. - Common Stock Company overview from Wikipedia
Oramed Pharmaceuticals Inc., is a publicly traded company engaged in the development of oral drug delivery systems – most notably an oral insulin capsule for treating type 2 diabetes. The company was founded in 2006 and is headquartered in Jerusalem. Its shares are listed on the NASDAQ Capital Market and the Tel Aviv Stock Exchange.
Read more
Oramed Pharmaceuticals Inc. (Hebrew: אורמד), is a publicly traded company engaged in the development of oral drug delivery systems – most notably an oral insulin capsule for treating type 2 diabetes. The company was founded in 2006 and is headquartered in Jerusalem. Its shares are listed on the NASDAQ Capital Market and the Tel Aviv Stock Exchange.
History
Oramed Pharmaceuticals was founded in 2006 by Miriam Kidron, a scientist at the Hadassah University Hospital in Jerusalem, and her son Nadav Kidron.
Product pipeline
Oramed considers its flagship product to be an oral insulin capsule developed to treat sufferers of type 2 diabetes. The Company is currently conducting Phase 3 trials, under the FDA, for oral insulin in Type 2 diabetes.
In addition to the oral insulin capsule, Oramed is developing an exenatide-based capsule designed to balance blood sugar levels and control appetite, and is conducting clinical trials for the treatment of NASH with oral insulin.
In 2021, Oramed created a subsidiary, Oravax Medical, to bring an oral Covid-19 vaccine to market.
In January 2023, a Phase 3 trial of Oramed's orally administered insulin for Type 2 diabetes patients failed, thus causing the share price to plunge. The company has mentioned that the pill worked for a subset of the population and will pursue a Phase 3 trial for that subset.
In May 2023, Ben Shapiro invested $4.7 million and was named to the board of directors.
On May 15, 2023, it was reported that Oramed's insulin pill was approved in China and will work with a Chinese firm to apply for marketing authorizations.
Subsidiaries
OraTech Pharmaceuticals is a joint venture formed by Oramed Pharmaceuticals and Hefei Tianhui Biotech, to commercialize its insulin capsule and is expected to list on the NASDAQ sometime in 2025.
Source: Wikipedia, CC BY-SA 4.0 · View on Wikipedia ↗
ORMP Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
Price
$4.83
Market Cap
$197.7K
P/E (TTM)
0.0
EPS (TTM)
$1.50
Revenue (TTM)
$2M
Div Yield
—
ROE
37.0%
Debt/Equity
—
52W Range
$2 – $5
ORMP Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
Configure
10-Year Performance Revenue, net income, margins and EPS trends
Revenue & Net Income
$2M
2017-08-31
→
2025-12-31
EPS
$1.50
2022-12-31
→
2025-12-31
Free Cash Flow
$-9M
2019-08-31
→
2025-12-31
Margins
3202.5%
2025-12-31
→
2025-12-31
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
Metric
5Y trend
ORMP
Peer Median
P/E (TTM)
0.0
23.4
P/S (TTM)
0.1
11.2
P/B
0.0
2.5
Price / FCF
-0.0
—
Profitability Gross, operating and net margins; ROE, ROA, ROIC
Metric
5Y trend
ORMP
Peer Median
Gross Margin
0.65%
82.8%
Operating Margin
-754.4%
—
Net Profit Margin
3202.5%
-199.7%
ROA
33.2%
-34.8%
ROE
37.0%
-33.2%
ROIC
-6.4%
—
Financial Health Debt, liquidity, solvency — balance sheet strength
Metric
5Y trend
ORMP
Peer Median
Current Ratio
7.0
1.5
Quick Ratio
2.7
—
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
Metric
5Y trend
ORMP
Peer Median
Revenue YoY
-50.4%
—
Revenue CAGR 3Y
-9.6%
—
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
Metric
5Y trend
ORMP
Peer Median
Dividends Yield, payout ratio, dividend history, 5Y CAGR
Dividend Yield
—
Payout Ratio
—
5Y Div CAGR
—
| Ex-date | Amount |
|---|---|
| Jan. 16, 2026 | $0.2500 |
ORMP Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
SELL
6 analysts
- Strong Buy 0 0.0%
- Buy 0 0.0%
- Hold 3 50.0%
- Sell 1 16.7%
- Strong Sell 2 33.3%
12-Month Price Target
1 analysts · 2026-08-17
Low
$6.25
High
$6.25
Median target
$6.25
+29.4%
Mean target
$6.25
+29.4%
Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
Avg Surprise
0.32%
| Period | EPS Actual | EPS Est | Surprise |
|---|---|---|---|
| Dec. 31, 2025 | $0.24 | $0.00 | 0.24% |
| Sept. 30, 2025 | $1.12 | $-0.04 | 1.2% |
| June 30, 2025 | $0.31 | $-0.04 | 0.35% |
| March 31, 2025 | $-0.19 | $-0.01 | -0.18% |
| Dec. 31, 2024 | $0.00 | $-0.03 | 0.03% |
Peer comparison (GICS sub-industry) Key metrics vs sector peers
| Ticker | Market Cap | P/E | Rev YoY | Net Margin | ROE | Gross Margin |
|---|---|---|---|---|---|---|
| ORMP | $112M | 1.9 | -50.4% | 3202.5% | 37.0% | 0.65% |
| ANTX | $31M | -1.0 | — | — | -57.7% | — |
| SIGA | $438M | 19.1 | -31.8% | 24.6% | 11.4% | — |
| DERM | — | -16.4 | 10.2% | -18.5% | -44.7% | — |
| AARD | $286M | -4.5 | — | — | -47.3% | — |
| LENZ | $502M | -5.6 | — | -430.2% | -33.5% | — |
| NRXP | — | — | — | — | — | — |
| LLY | — | 46.8 | 44.7% | 31.7% | 101.2% | — |
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Income Statement 17
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2M | · | $1M | $3M | · | $3M | $3M | $2M | $2M | |
| Cost of Revenue | $2M | · | · | · | · | · | $90.0K | $-86.0K | $187.0K | |
| Gross Profit | $13.0K | · | · | · | · | · | · | · | · | |
| R&D Expense | $6M | $6M | $9M | $28M | · | $10M | $14M | $12M | $10M | |
| SG&A Expense | $9M | $6M | $8M | $14M | · | $4M | $4M | $4M | $3M | |
| Operating Income | $-15M | $-13M | $-16M | $-41M | · | $-12M | $-15M | $-14M | $-11M | |
| Interest Expense | · | · | $2M | · | · | · | · | · | · | |
| Interest Income | · | · | $10.0K | · | · | · | · | · | · | |
| Other Non-op | $-606.0K | $-27.0K | $13.3K | $3M | · | · | · | · | · | |
| Pretax Income | $75M | $-16M | $5M | $-38M | · | $-12M | $-14M | $-13M | $-10M | |
| Income Tax | $11M | $3M | · | $100.0K | · | · | $300.0K | · | $400.0K | |
| Net Income | $64M | $-19M | $5M | $-37M | · | $-12M | $-14M | $-13M | $-10M | |
| EPS (Basic) | $1.53 | $-0.48 | $0.14 | $-0.94 | · | · | · | · | · | |
| EPS (Diluted) | $1.50 | $-0.48 | $0.14 | $-0.94 | · | · | · | · | · | |
| Shares (Basic) | 41,402,997 | 40,850,446 | 40,315,068 | 38,997,649 | · | · | · | · | · | |
| Shares (Diluted) | 42,418,644 | 40,850,446 | 40,566,901 | 38,997,649 | · | · | · | · | · | |
| EBITDA | $-15M | · | $-16M | $-41M | · | $-12M | $-15M | · | · |
Balance Sheet 23
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $46M | $54M | $9M | $40M | · | $19M | $3M | $5M | $4M | |
| Short-term Investments | $5M | $3M | · | · | $8M | $3M | · | $5M | · | |
| Prepaid Expense | $3M | $1M | $537.0K | $1M | · | $611.0K | $1M | $574.0K | · | |
| Current Assets | $133M | $143M | $163M | $157M | $148M | $41M | $33M | $31M | · | |
| PP&E (Net) | $586.0K | $698.0K | $873.0K | $815.0K | $388.0K | $99.0K | $24.0K | $17.0K | · | |
| Other Non-current Assets | $44.0K | $32.0K | $27.0K | · | · | · | · | · | · | |
| Total Assets | $231M | $155M | $221M | $162M | $178M | $45M | $35M | $47M | · | |
| Accounts Payable | $443.0K | $789.0K | $551.0K | $4M | $5M | $2M | $3M | $2M | · | |
| Accrued Liabilities | $1M | $402.0K | $605.0K | · | · | · | · | · | · | |
| Short-term Debt | $652.0K | $329.0K | $51M | · | · | · | $3M | $2M | · | |
| Current Liabilities | $19M | $6M | $53M | $6M | $7M | $5M | $5M | $5M | · | |
| Capital Leases | $540.0K | $156.0K | $342.0K | $647.0K | $370.0K | $31.0K | · | · | · | |
| Deferred Tax | $8M | · | · | · | · | · | · | · | · | |
| Other Non-current Liabilities | · | $60.0K | $63.0K | · | · | $211.0K | $271.0K | $313.0K | · | |
| Long-term Debt | · | · | · | $25.0K | $12M | · | $10M | $11M | · | |
| Total Debt | · | · | $51M | · | · | · | $3M | · | · | |
| Common Stock | $472.0K | $480.0K | $485.0K | $476.0K | $459.0K | $284.0K | $208.0K | $207.0K | · | |
| Paid-in Capital | · | · | · | $314M | $293M | $125M | · | · | · | |
| Retained Earnings | $-123M | $-177M | $-158M | $-163M | $-127M | $-93M | $-81M | $-69M | · | |
| AOCI | · | · | · | · | · | · | · | $702.0K | · | |
| Stockholders' Equity | $200M | $145M | $164M | $152M | $166M | $33M | $19M | $31M | $19M | |
| Liabilities + Equity | $231M | $155M | $221M | $162M | $178M | $45M | $35M | $47M | · | |
| Shares Outstanding | 39,275,006 | 39,920 | 40,339,000 | 39,564,000 | 38,158 | 23,675,530 | 17,383,359 | 17,369,875 | · |
Cash Flow 12
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $6M | $4M | $4M | $12M | · | $465.0K | $808.0K | $2M | $2M | |
| Deferred Tax | $8M | · | · | · | · | · | · | · | · | |
| Operating Cash Flow | $-9M | $-8M | $-10M | $-28M | · | $-12M | $-13M | $-15M | $-6M | |
| CapEx | $9.0K | $18.0K | $254.0K | $496.0K | · | $82.0K | $15.0K | $5.0K | $7.0K | |
| Investing Cash Flow | $5M | $106M | $-73M | $30M | · | $5M | $11M | $-7M | $4M | |
| Stock Issued | · | · | $2M | $12M | · | · | · | · | · | |
| Stock Repurchased | $5M | $2M | · | · | · | · | · | · | · | |
| Net Stock Activity | $-5M | · | $2M | $11M | · | · | · | · | · | |
| Financing Cash Flow | $-5M | $-52M | $52M | $11M | · | $24M | · | $23M | $2M | |
| Net Change in Cash | $-8M | $45M | $-31M | $13M | · | $16M | $-2M | $1M | $62.0K | |
| Taxes Paid | · | $2M | · | $2M | · | · | $300.0K | · | $400.0K | |
| Free Cash Flow | $-9M | · | $-11M | $-28M | · | $-13M | $-13M | · | · |
Profitability 8
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 0.65% | · | · | · | · | · | · | · | · | |
| Operating Margin | -754.4% | · | -1176.8% | -1502.0% | · | -433.8% | -541.3% | · | · | |
| Net Margin | 3202.5% | · | 412.3% | -1397.1% | · | -424.8% | -531.1% | · | · | |
| Pretax Margin | 3766.2% | · | 379.7% | · | · | -424.8% | -520.0% | · | · | |
| EBITDA Margin | -754.4% | · | -1176.8% | -1502.0% | · | -433.8% | -541.3% | · | · | |
| ROA | 33.2% | · | 2.9% | -22.2% | · | -29.0% | -35.0% | · | · | |
| ROE | 37.0% | · | 3.5% | -23.7% | · | -47.0% | -70.1% | · | · | |
| ROIC | -6.4% | · | · | · | · | · | -67.6% | · | · |
Liquidity & Solvency 4
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 7.0 | · | 3.1 | 27.3 | · | 8.9 | 6.3 | · | · | |
| Quick Ratio | 2.7 | · | 1.3 | 0.7 | · | 5.0 | 1.3 | · | · | |
| Debt / Equity | · | · | 0.3 | · | · | · | 0.1 | · | · | |
| Interest Coverage | · | · | -7.7 | · | · | · | · | · | · |
Efficiency 1
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | · | 0.0 | 0.0 | · | 0.1 | 0.1 | · | · |
Growth Rates 2
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | · | · | -50.4% | · | · | · | · | · | · | |
| Revenue CAGR 3Y | -9.6% | · | · | · | · | · | · | · | · |
Valuation (TTM) 14
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $2M | $3M | $1M | $3M | · | $3M | $3M | $2M | $2M | |
| Net Income TTM | $64M | $-19M | $5M | $-37M | · | $-12M | $-14M | $-13M | $-10M | |
| Market Cap | $112M | · | $93M | $476M | · | $83M | $58M | · | · | |
| Enterprise Value | · | · | $77M | · | · | · | $53M | · | · | |
| P/E | 1.9 | -5.0 | 16.5 | -12.8 | · | · | · | · | · | |
| P/S | 56.0 | · | 69.5 | 176.1 | · | 30.5 | 21.4 | · | · | |
| P/B | 0.6 | · | 0.6 | 3.1 | · | 2.5 | 3.0 | · | · | |
| P / Tangible Book | 0.6 | 0.7 | 0.6 | 3.1 | · | 2.5 | · | · | · | |
| P / Cash Flow | -12.2 | · | -9.1 | -17.0 | · | -6.6 | -4.5 | · | · | |
| P / FCF | -12.2 | · | -8.8 | -16.8 | · | -6.6 | -4.5 | · | · | |
| EV / EBITDA | · | · | -4.9 | · | · | · | -3.6 | · | · | |
| EV / FCF | · | · | -7.3 | · | · | · | -4.1 | · | · | |
| EV / Revenue | · | · | 57.8 | · | · | · | 19.8 | · | · | |
| Earnings Yield | 52.6% | -19.8% | 6.1% | -7.8% | · | · | · | · | · |
Income Statement 17
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | · | · | $0 | · | · | $2M | · | · | · | · | $0 | · | $674.0K | $666.0K | $681.0K | $682.0K | |
| Cost of Revenue | · | · | $0 | · | · | $2M | · | · | · | · | · | · | · | · | · | · | |
| Gross Profit | · | · | $0 | · | · | $13.0K | · | · | · | · | · | · | · | · | · | · | |
| R&D Expense | · | $2M | $2M | $1M | $1M | $2M | $1M | $2M | $1M | $1M | $2M | $957.0K | $2M | $4M | $7M | $5M | |
| SG&A Expense | $3M | $2M | $4M | $1M | $1M | $2M | $2M | $847.0K | $2M | $2M | $2M | $3M | $2M | $1M | $3M | $3M | |
| Operating Expenses | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $11.0K | |
| Operating Income | $-3M | $-4M | $-6M | $-2M | $-2M | $-4M | $-4M | $-3M | $-3M | $-3M | $-4M | $-3M | $-4M | $-5M | $-10M | $-8M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $592.0K | · | $826.0K | · | · | · | · | |
| Other Non-op | $-4.0K | $-100.0K | $-74M | $61M | · | $-143.0K | $-2M | $-15M | $14M | $4M | $-4M | $435.0K | $2M | $2M | $1M | $1M | |
| Pretax Income | $102M | $49M | $10M | $59M | $13M | $-7M | $-10M | $-19M | $11M | $2M | $13M | $-3M | $-1M | · | $-9M | $-7M | |
| Income Tax | $23M | $11M | $-212.0K | $11M | $-126.0K | $584.0K | $416.0K | $1M | $2M | · | · | · | · | · | $0 | $100.0K | |
| Net Income | $78M | $38M | $10M | $48M | $13M | $-8M | $-10M | $-20M | $9M | $2M | $13M | $-3M | $-1M | $-3M | $-8M | $-7M | |
| EPS (Basic) | $1.90 | $0.94 | $0.24 | $1.16 | $0.32 | $-0.19 | $-0.26 | $-0.48 | $0.22 | $0.04 | $0.33 | $-0.08 | $-0.03 | $-0.08 | $-1.66 | $0.18 | |
| EPS (Diluted) | $1.84 | $0.91 | $0.25 | $1.13 | $0.31 | $-0.19 | $-0.26 | $-0.48 | $0.22 | $0.04 | $0.33 | $-0.08 | $-0.03 | $-0.08 | $-1.66 | $0.18 | |
| Shares (Basic) | 41,040,479 | 40,773,866 | -83,325,572 | 41,756,301 | 41,743,486 | 41,228,782 | -81,842,111 | 40,896,845 | 40,959,759 | 40,835,953 | -80,397,680 | 40,445,896 | 40,225,594 | 40,041,258 | -77,577,522 | 39,100,231 | |
| Shares (Diluted) | 42,501,252 | 41,970,186 | -84,194,067 | 42,774,504 | 42,609,425 | 41,228,782 | -83,201,413 | 40,896,845 | 41,591,007 | 41,564,007 | -80,145,847 | 40,445,896 | 40,225,594 | 40,041,258 | -77,577,522 | 39,100,231 | |
| EBITDA | $-3M | $-4M | · | $-2M | $-2M | $-4M | · | $-3M | $-3M | $-3M | · | $-3M | $-4M | $-5M | · | $-8M |
Balance Sheet 22
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $15M | $13M | $46M | $52M | $16M | · | $54M | · | $10M | $19M | · | · | · | · | $40M | · | |
| Short-term Investments | $846.0K | $5M | $5M | $5M | $2M | $4M | $3M | $57M | $66M | $78M | · | $49.4K | $943.0K | $2M | · | $5M | |
| Prepaid Expense | $2M | $2M | $3M | $1M | $1M | $832.0K | $1M | $474.0K | $533.0K | $501.0K | $537.0K | $666.0K | $769.0K | · | $1M | · | |
| Current Assets | $53M | $68M | $133M | $136M | $99M | $131M | $143M | $143M | $153M | $177M | $163M | $176M | $151M | $155M | $157M | $160M | |
| PP&E (Net) | $532.0K | $561.0K | $586.0K | $614.0K | $645.0K | $671.0K | $698.0K | $718.0K | $765.0K | $819.0K | $873.0K | $923.0K | $945.0K | $977.0K | $815.0K | $535.0K | |
| Other Non-current Assets | $49.0K | $46.0K | $44.0K | $40.0K | $38.0K | $32.0K | $32.0K | · | · | · | $27.0K | · | · | · | · | · | |
| Total Assets | $370M | $269M | $231M | $220M | $162M | $148M | $155M | $165M | $184M | $204M | $221M | $231M | $156M | $160M | $162M | $164M | |
| Accounts Payable | $374.0K | $481.0K | $443.0K | $560.0K | $715.0K | $509.0K | $789.0K | $5M | $3M | $1M | $551.0K | $3M | $828.0K | $4M | $4M | $4M | |
| Accrued Liabilities | $1M | $1M | $1M | $585.0K | $841.0K | $800.0K | $402.0K | · | · | · | $605.0K | · | · | · | · | · | |
| Short-term Debt | · | · | · | $1.0K | $34.0K | $36.0K | · | · | · | $32M | $51M | $75M | $3.0K | $1.0K | · | · | |
| Current Liabilities | $11M | $11M | $19M | $6M | $4M | $5M | $6M | $5M | $4M | $34M | $53M | $78M | $1M | $5M | $6M | $7M | |
| Capital Leases | $484.0K | $493.0K | $540.0K | $589.0K | $648.0K | $120.0K | $156.0K | $186.0K | $236.0K | $272.0K | $342.0K | $389.0K | $488.0K | $564.0K | $647.0K | $672.0K | |
| Deferred Tax | $40M | $18M | $8M | $8M | · | · | · | · | · | · | · | · | · | · | · | · | |
| Other Non-current Liabilities | · | · | · | · | · | · | $60.0K | $60.0K | $60.0K | · | $63.0K | · | · | · | · | · | |
| Long-term Debt | · | · | · | · | · | · | · | · | · | · | · | $75M | · | · | · | $5M | |
| Total Debt | · | · | · | $1.0K | $34.0K | $36.0K | · | · | · | $32M | · | $75M | $3.0K | $1.0K | · | · | |
| Common Stock | $495.0K | $491.0K | $472.0K | $490.0K | $491.0K | $491.0K | $480.0K | $484.0K | $488.0K | $487.0K | $485.0K | $484.0K | $484.0K | $481.0K | $476.0K | $470.0K | |
| Paid-in Capital | · | · | · | · | · | · | · | · | · | · | · | · | $319M | $317M | · | $308M | |
| Retained Earnings | $-7M | $-85M | $-123M | $-123M | $-171M | $-184M | $-177M | $-166M | $-147M | $-156M | $-158M | $-171M | $-168M | $-166M | $-163M | $-155M | |
| Stockholders' Equity | $317M | $238M | $200M | $203M | $155M | $141M | $146M | $156M | $177M | $167M | $164M | $149M | $152M | $151M | $152M | $154M | |
| Liabilities + Equity | $370M | $269M | $231M | $220M | $162M | $148M | $155M | $165M | $184M | $204M | $221M | $231M | $156M | $160M | $162M | $164M | |
| Shares Outstanding | 41,314,211 | 40,926,081 | 39,275,006 | 40,838,226 | 40,845,087 | 40,850,455 | 39,919,545 | 40,209,575 | 40,628,924 | 40,519,160 | 40,338,979 | 40,282,688 | 40,219,396 | 39,969,979 | 39,563,888 | 39,113,236 |
Cash Flow 12
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $1M | $2M | $2M | $719.0K | $800.0K | $2M | $1M | $301.0K | $1M | $1M | $1M | $852.0K | $2M | $173.0K | $3M | $3M | |
| Deferred Tax | $22M | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Operating Cash Flow | $-200.0K | $-3M | $-466.0K | $-2M | $-4M | $-4M | $-2M | $-7M | $2M | $-1M | $-1M | $-694.0K | $-3M | $-6M | $-8M | $-2M | |
| CapEx | $2.0K | $5.0K | $2.0K | $0 | $4.0K | $3.0K | $11.0K | $5.0K | $0 | $2.0K | $3.0K | $32.0K | $20.0K | $199.0K | $308.0K | $121.0K | |
| Investing Cash Flow | $4M | $-19M | $-2M | $38M | $-55M | $24M | $15M | $-34M | $95M | $30M | $30M | $-75M | $-15M | $-13M | $11M | $1M | |
| Stock Issued | · | · | · | · | · | · | · | · | · | · | $0 | $-2.0K | $0 | $2M | $4M | $-3M | |
| Stock Repurchased | · | · | $4M | $361.0K | · | · | $1M | · | · | · | · | · | · | · | · | · | |
| Dividends Paid | $78.0K | $10M | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $-2M | $-10M | $-4M | $-361.0K | · | · | $-1M | $-1M | $-31M | $-19M | $-25M | $75M | $0 | $2M | $4M | $4M | |
| Net Change in Cash | $2M | $-33M | $-6M | $36M | $-59M | $20M | $12M | $-43M | $66M | $10M | $4M | $-1M | $-17M | $-16M | $7M | $3M | |
| Taxes Paid | · | · | · | $-7M | · | · | · | · | · | · | · | $527.0K | $3M | $308.0K | · | $167.0K | |
| Free Cash Flow | · | $-3M | · | · | · | $-4M | · | · | · | $-1M | · | · | · | $-6M | · | · |
Profitability 8
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | · | · | · | · | · | 0.65% | · | · | · | · | · | · | · | · | · | · | |
| Operating Margin | · | · | · | · | · | -225.0% | · | · | · | · | · | · | -562.5% | -782.0% | · | -1200.7% | |
| Net Margin | · | · | · | · | · | -382.1% | · | · | · | · | · | · | -177.2% | -542.2% | · | -1063.5% | |
| Pretax Margin | · | · | · | · | · | -352.9% | · | · | · | · | · | · | · | · | · | -1048.8% | |
| EBITDA Margin | · | · | · | · | · | -225.0% | · | · | · | · | · | · | -562.5% | -782.0% | · | -1200.7% | |
| ROA | 29.4% | 18.4% | · | 25.1% | 7.7% | -4.3% | · | -9.9% | 5.4% | 0.85% | · | -1.6% | -0.75% | -2.2% | · | -5.9% | |
| ROE | 33.1% | 20.2% | · | 26.9% | 8.0% | -5.0% | · | -12.8% | 5.6% | 0.97% | · | -2.1% | -0.78% | -2.3% | · | -6.5% | |
| ROIC | -0.67% | -1.2% | · | -0.97% | -1.6% | -3.5% | · | -2.1% | -1.5% | · | · | · | · | · | · | -5.4% |
Liquidity & Solvency 4
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 5.0 | 6.5 | · | 22.2 | 26.8 | 23.9 | · | 27.1 | 41.1 | 5.3 | · | 2.2 | 141.5 | 31.2 | · | 24.5 | |
| Quick Ratio | 1.5 | 1.7 | · | 9.3 | 4.8 | 0.7 | · | 10.9 | 20.4 | 2.9 | · | 0.0 | 0.9 | 0.5 | · | 0.8 | |
| Debt / Equity | · | · | · | 0.0 | 0.0 | 0.0 | · | · | · | 0.2 | · | 0.5 | 0.0 | 0.0 | · | · | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | -5.0 | · | -3.5 | · | · | · | · |
Efficiency 1
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | · | · | · | 0.0 | · | · | · | · | · | · | 0.0 | 0.0 | · | 0.0 |
Valuation (TTM) 15
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | · | · | · | · | · | · | · | $3M | $3M | $3M | · | $3M | $3M | $3M | · | $3M | |
| Net Income TTM | $178M | $92M | · | $34M | $-5M | $-17M | · | $-12M | $6M | $-6M | · | $-15M | $-22M | $-32M | · | $-36M | |
| Market Cap | $199M | $139M | · | $108M | $92M | $87M | · | $98M | $104M | $118M | · | $105M | $144M | $87M | · | $253M | |
| Enterprise Value | · | · | · | $51M | $74M | · | · | · | · | $54M | · | · | · | · | · | · | |
| P/E | 1.1 | 1.6 | · | 3.4 | -16.1 | -5.2 | · | -8.1 | 17.1 | -19.5 | · | -261.0 | 10.5 | 3.4 | · | 7.0 | |
| P/S | · | · | · | · | · | · | · | 36.4 | 38.7 | 43.9 | · | 39.0 | 53.4 | 32.4 | · | 94.0 | |
| P/B | 0.6 | 0.6 | · | 0.5 | 0.6 | 0.6 | · | 0.6 | 0.6 | 0.7 | · | 0.7 | 1.0 | 0.6 | · | 1.6 | |
| P / Tangible Book | 0.6 | 0.6 | · | 0.5 | 0.6 | 0.6 | · | 0.6 | 0.6 | 0.7 | · | 0.7 | 1.0 | 0.6 | · | 1.6 | |
| P / Cash Flow | · | -47.7 | · | · | · | -24.8 | · | · | · | -80.2 | · | · | · | -15.7 | · | · | |
| P / FCF | · | -47.7 | · | · | · | -24.8 | · | · | · | -80.1 | · | · | · | -15.2 | · | · | |
| EV / EBITDA | · | · | · | -20.9 | -29.9 | · | · | · | · | -18.2 | · | · | · | · | · | · | |
| EV / FCF | · | · | · | · | · | · | · | · | · | -36.6 | · | · | · | · | · | · | |
| EV / Revenue | · | · | · | · | · | · | · | · | · | 20.0 | · | · | · | · | · | · | |
| Earnings Yield | 87.1% | 63.5% | · | 29.2% | -6.2% | -19.2% | · | -12.3% | 5.8% | -5.1% | · | -0.38% | 9.5% | 29.4% | · | 14.3% | |
| Payout Ratio | · | 27.1% | · | · | · | · | · | · | · | · | · | · | · | · | · | · |
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
Income Statement
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Revenue | $2M | — | $1M | $3M | — |
| Gross Margin % | 0.65% | — | — | — | — |
| Operating Margin % | -754.4% | — | -1176.8% | -1502.0% | — |
| Net Income | $64M | $-19M | $5M | $-37M | — |
| Diluted EPS | $1.50 | $-0.48 | $0.14 | $-0.94 | — |
Balance Sheet
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Debt / Equity | — | — | 0.3 | — | — |
| Current Ratio | 7.0 | — | 3.1 | 27.3 | — |
| Quick Ratio | 2.7 | — | 1.3 | 0.7 | — |
Cash Flow
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Free Cash Flow | $-9M | — | $-11M | $-28M | — |
My Metrics Your personal watchlist — selected rows from Full Fundamentals
📊
Pick the metrics that matter to you — click the ➕ next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.
Institutional owners (13F) 88 filers · $64.4M total · As of June 30, 2026
Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
Institutional activity — Q2 2026 vs prior quarter
| New positions | Exited positions | Increased | Decreased | Net shares change |
|---|---|---|---|---|
| 30 (+13 vs prior Q) | 8 (0 vs prior Q) | 19 (-1 vs prior Q) | 19 (+5 vs prior Q) | -209K |
Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.
| Institution | Value | Shares | % of tracked 13F | Type |
|---|---|---|---|---|
| Aquamarine Financial (Cayman) Ltd | $12,083,562 | 2,512,175 | 18.77% | Shares |
| Gem Investment Advisors, LLC | $9,614,238 | 1,998,802 | 14.94% | Shares |
| MERCER GLOBAL ADVISORS INC /ADV | $9,189,697 | 1,910,540 | 14.28% | Shares |
| Murchinson Ltd. | $6,206,314 | 1,290,294 | 9.64% | Shares |
| SB Capital Management Inc | $5,415,000 | 1,900,000 | 8.41% | Shares |
| BML Capital Management, LLC | $4,166,754 | 866,269 | 6.47% | Shares |
| BOOTHBAY FUND MANAGEMENT, LLC | $2,783,249 | 578,638 | 4.32% | Shares |
| GEODE CAPITAL MANAGEMENT, LLC | $2,162,008 | 449,482 | 3.36% | Shares |
| STATE STREET CORP | $1,164,501 | 242,100 | 1.81% | Shares |
| Rathbones Group PLC | $1,120,816 | 233,018 | 1.74% | Shares |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $1,105,732 | 229,882 | 1.72% | Shares |
| GOLDMAN SACHS GROUP INC | $950,908 | 197,694 | 1.48% | Shares |
| RENAISSANCE TECHNOLOGIES LLC | $884,078 | 183,800 | 1.37% | Shares |
| DIMENSIONAL FUND ADVISORS LP | $784,896 | 163,180 | 1.22% | Shares |
| STRS OHIO | $643,578 | 133,800 | 1.00% | Shares |
| O'SHAUGHNESSY ASSET MANAGEMENT, LLC | $495,247 | 102,962 | 0.77% | Shares |
| JANE STREET GROUP, LLC | $470,606 | 97,839 | 0.73% | Shares |
| Hillsdale Investment Management Inc. | $429,533 | 89,300 | 0.67% | Shares |
| RITHOLTZ WEALTH MANAGEMENT | $405,709 | 84,347 | 0.63% | Shares |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $402,280 | 83,634 | 0.63% | Shares |
| AMERICAN CENTURY COMPANIES INC | $287,518 | 59,775 | 0.45% | Shares |
| XTX Topco Ltd | $240,130 | 49,923 | 0.37% | Shares |
| Nuveen, LLC | $223,203 | 46,404 | 0.35% | Shares |
| DEUTSCHE BANK AG\ | $159,682 | 33,198 | 0.25% | Shares |
| PRELUDE CAPITAL MANAGEMENT, LLC | $157,350 | 32,713 | 0.24% | Shares |
| BAILARD, INC. | $156,219 | 32,478 | 0.24% | Shares |
| RHUMBLINE ADVISERS | $147,281 | 30,621 | 0.23% | Shares |
| Bank of New York Mellon Corp | $143,016 | 29,733 | 0.22% | Shares |
| ALGERT GLOBAL LLC | $139,288 | 28,958 | 0.22% | Shares |
| WELLS FARGO & COMPANY/MN | $137,080 | 28,499 | 0.21% | Shares |
| Connor, Clark & Lunn Investment Management Ltd. | $121,246 | 25,207 | 0.19% | Shares |
| CITADEL ADVISORS LLC | $120,250 | 25,000 | 0.19% | Call option |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $107,263 | 22,300 | 0.17% | Shares |
| MILLENNIUM MANAGEMENT LLC | $105,151 | 21,861 | 0.16% | Shares |
| PNC Financial Services Group, Inc. | $101,972 | 21,200 | 0.16% | Shares |
| Redwood Family Wealth LLC | $99,783 | 20,745 | 0.16% | Shares |
| BANK OF AMERICA CORP /DE/ | $91,621 | 19,048 | 0.14% | Shares |
| MORGAN STANLEY | $87,994 | 18,294 | 0.14% | Shares |
| Sage Capital Management, LLC | $86,474 | 17,977 | 0.13% | Shares |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $75,378 | 15,671 | 0.12% | Shares |
| VANGUARD FIDUCIARY TRUST CO | $67,811 | 14,098 | 0.11% | Shares |
| CITIGROUP INC | $66,590 | 13,844 | 0.10% | Shares |
| JPMORGAN CHASE & CO | $65,461 | 14,108 | 0.10% | Shares |
| Invesco Ltd. | $65,272 | 13,570 | 0.10% | Shares |
| Y-Intercept (Hong Kong) Ltd | $61,650 | 12,817 | 0.10% | Shares |
| Engineers Gate Manager LP | $61,077 | 12,698 | 0.09% | Shares |
| Altshuler Shaham Ltd | $53,925 | 11,211 | 0.08% | Shares |
| WEALTH ENHANCEMENT ADVISORY SERVICES, LLC | $52,096 | 12,895 | 0.08% | Shares |
| Glass Jacobson Investment Advisors llc | $50,698 | 10,540 | 0.08% | Shares |
| Police & Firemen's Retirement System of New Jersey | $50,115 | 10,419 | 0.08% | Shares |
| MARSHALL WACE, LLP | $50,024 | 10,400 | 0.08% | Shares |
| Hudson Bay Capital Management LP | $49,375 | 10,265 | 0.08% | Shares |
| BNP PARIBAS FINANCIAL MARKETS | $47,706 | 9,918 | 0.07% | Shares |
| Steward Partners Investment Advisory, LLC | $42,453 | 8,826 | 0.07% | Shares |
| BARCLAYS PLC | $27,917 | 5,804 | 0.04% | Shares |
| NEW YORK STATE COMMON RETIREMENT FUND | $25,974 | 5,400 | 0.04% | Shares |
| NORTHERN TRUST CORP | $25,503 | 5,302 | 0.04% | Shares |
| Tower Research Capital LLC (TRC) | $23,218 | 4,827 | 0.04% | Shares |
| OSAIC HOLDINGS, INC. | $20,283 | 4,217 | 0.03% | Shares |
| FEDERATED HERMES, INC. | $19,221 | 3,996 | 0.03% | Shares |
| N.E.W. Advisory Services LLC | $16,495 | 3,429 | 0.03% | Shares |
| Legal & General Group Plc | $15,979 | 3,322 | 0.02% | Shares |
| CITADEL ADVISORS LLC | $15,565 | 3,236 | 0.02% | Shares |
| Ameritas Investment Partners, Inc. | $14,853 | 3,088 | 0.02% | Shares |
| HUNTINGTON NATIONAL BANK | $14,440 | 3,002 | 0.02% | Shares |
| Pioneer Family Office, LLC | $14,430 | 3,000 | 0.02% | Shares |
| Russell Investments Group, Ltd. | $13,088 | 2,721 | 0.02% | Shares |
| UBS Group AG | $12,987 | 2,700 | 0.02% | Shares |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | $7,576 | 1,575 | 0.01% | Shares |
| MetLife Investment Management, LLC | $7,037 | 1,463 | 0.01% | Shares |
| BlackRock, Inc. | $6,768 | 1,407 | 0.01% | Shares |
| ROYAL BANK OF CANADA | $6,000 | 1,246 | 0.01% | Shares |
| MCF Advisors LLC | $5,162 | 1,073 | 0.01% | Shares |
| Caitlin John, LLC | $4,810 | 1,000 | 0.01% | Shares |
| McIlrath & Eck, LLC | $3,400 | 1,000 | 0.01% | Shares |
| Sterling Capital Management LLC | $3,300 | 686 | 0.01% | Shares |
| IFP Advisors, Inc | $2,405 | 500 | 0.00% | Shares |
| PROEQUITIES, INC. | $2,310 | 1,000 | 0.00% | Shares |
| Golden State Wealth Management, LLC | $1,458 | 303 | 0.00% | Shares |
| JONES FINANCIAL COMPANIES LLLP | $999 | 214 | 0.00% | Shares |
| HRT FINANCIAL LP | $469 | 97,582 | 0.00% | Shares |
| FMR LLC | $332 | 69 | 0.00% | Shares |
| SBI Securities Co., Ltd. | $284 | 59 | 0.00% | Shares |
| PRICE T ROWE ASSOCIATES INC /MD/ | $135 | 27,909 | 0.00% | Shares |
| TrinityBridge Ltd | $56 | 11,675 | 0.00% | Shares |
| HARBOUR INVESTMENTS, INC. | $48 | 10 | 0.00% | Shares |
| Caitong International Asset Management Co., Ltd | $29 | 6 | 0.00% | Shares |
| ACADIAN ASSET MANAGEMENT LLC | $8 | 1,691 | 0.00% | Shares |
Company insiders 30 insiders · 13 officers · 16 directors
| Insider | Role | Last activity | Shares owned | Buys 12m | Sells 12m | Net 12m |
|---|---|---|---|---|---|---|
| Nadav Kidron | President and CEO | March 30, 2026 F | 3,422,243 | 0 | 0 | $0 |
| Avraham Gabay | Chief Financial Officer | July 1, 2026 S | 671,785 | 0 | 1 | $-330,854 |
| David Silberman | Chief Financial Officer | Jan. 4, 2024 A | 366,500 | 0 | 0 | $0 |
| Hilla Eisenberg | CFO, Treasurer and Secretary | Feb. 26, 2019 A | — | 0 | 0 | $0 |
| Yifat Hen Zommer | CFO, Treasurer and Secretary | June 30, 2017 A | 46,560 | 0 | 0 | $0 |
| Chaime Orlev | CFO, Treasurer and Secretary | Oct. 12, 2008 A | — | 0 | 0 | $0 |
| Joshua Hexter | COO & CBO | July 2, 2026 M | 1,073,384 | 0 | 1 | $-611,020 |
| Miriam Kidron | Chief Scientific Officer | March 30, 2026 F | 1,133,138 | 0 | 0 | $0 |
| Netanel Derovan | Chief Legal Officer | May 26, 2023 A | 149,500 | 0 | 0 | $0 |
| Michael Rabinowitz | Chief Commercial Officer | Jan. 3, 2023 S | 126,143 | 0 | 0 | $0 |
| Michael Rabinowitz | Chief Commercial Officer | Jan. 3, 2022 A | 109,468 | 0 | 0 | $0 |
| Mark Daniel Hasleton | VP Business Development | Feb. 26, 2019 A | — | 0 | 0 | $0 |
| Ronald Edward Law | Chief Strategy Officer | March 20, 2017 A | — | 0 | 0 | $0 |
| Yehuda Reznick | Director | Dec. 31, 2025 A | 105,180 | 0 | 0 | $0 |
| Daniel Aghion | Director | Dec. 31, 2025 A | 113,441 | 0 | 0 | $0 |
| Benjamin Shapiro | Director | Dec. 31, 2025 A | 123,220 | 0 | 0 | $0 |
| Arie Mayer | Director | Dec. 31, 2025 A | 168,009 | 0 | 0 | $0 |
| Leonard Sank | Director | June 5, 2025 A | 134,531 | 0 | 0 | $0 |
| Yadin Rozov | Director | Jan. 4, 2024 A | 155,320 | 0 | 0 | $0 |
| Kevin Rakin | Director | March 21, 2022 S | 46,661 | 0 | 0 | $0 |
| Aviad Friedman | Director | Jan. 3, 2022 G | 0 | 0 | 0 | $0 |
| Gao Xiaoming | Director | Jan. 8, 2020 A | — | 0 | 0 | $0 |
| David Mark Slager | Director | April 15, 2019 A | 1,316,328 | 0 | 0 | $0 |
| Xiaopeng Li | Director | Aug. 2, 2017 P | 206,350 | 0 | 0 | $0 |
| Harold Jacob | Director | March 10, 2016 S | 16,396 | 0 | 0 | $0 |
| Michael Berelowitz | Director | Dec. 9, 2015 S | 22,896 | 0 | 0 | $0 |
| Gerald M Ostrov | Director | Feb. 23, 2015 A | 24,896 | 0 | 0 | $0 |
| REGALS CAPITAL MANAGEMENT LP | 10% owner | Dec. 23, 2015 X | 1,186,823 | 0 | 0 | $0 |
| Zeev Bronfeld | 10% owner | Sept. 27, 2011 S | 5,808,517 | 0 | 0 | $0 |
| Michael Young | — | May 27, 2004 S | 0 | 0 | 0 | $0 |
Insiders from SEC Form 3/4/5 filings; net = open-market P/S only
Activists & 5%+ owners 9 positions
Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.
| Filer | Filed | Stake | Status | Purpose | Filing |
|---|---|---|---|---|---|
| Oramed Pharmaceuticals Inc. | July 22, 2026 | 3.30% | Amendment | — | SEC |
| Nadav Kidron ×8 filings | Aug. 28, 2025 | 7.60% | Amendment | — | SEC |
| Regals Capital Management LP, Regals Fund LP, David M. Slager ×2 filings | July 20, 2018 | — | Initial filing | — | SEC |
| Hefei Tianhui Incubator of Technologies Co., Ltd | Jan. 6, 2016 | — | Initial filing | — | SEC |
| Leonard Sank | Dec. 15, 2014 | — | Initial filing | Passive investment | SEC |
| Miriam Kidron ×2 filings | Feb. 3, 2014 | — | Initial filing | — | SEC |
| Zeev Bronfeld | March 6, 2006 | — | Initial filing | Passive investment | SEC |
| Undisclosed reporting person | June 10, 2004 | — | Initial filing | — | SEC |
| Undisclosed reporting person | June 10, 2004 | — | Initial filing | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF ownership Held by 14 ETFs
Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.
| Fund | Weight | Units | As of | Source |
|---|---|---|---|---|
| IWC · iShares Trust | 0.03% | 114,970 SH | Aug. 8, 2026 | Daily |
| OMFS · Invesco Exchange-Traded Self-Indexe… | 0.01% | 7,046 SH | Aug. 8, 2026 | Daily |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0.01% | 29,637 SH | Aug. 8, 2026 | Daily |
| IWN · iShares Trust | 0.01% | 315,439 SH | Aug. 8, 2026 | Daily |
| AVSC · AMERICAN CENTURY ETF TRUST | 0.00% | 28,155 NS | May 31, 2026 | N-PORT |
| IWM · iShares Trust | 0.00% | 621,705 SH | Aug. 8, 2026 | Daily |
| DFAS · Dimensional ETF Trust | 0.00% | 26,896 NS | April 30, 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0.00% | 4,523 NS | April 30, 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0.00% | 36,536 NS | April 30, 2026 | N-PORT |
| AVUS · AMERICAN CENTURY ETF TRUST | 0.00% | 4,152 NS | May 31, 2026 | N-PORT |
| DFUS · Dimensional ETF Trust | 0.00% | 3,431 NS | April 30, 2026 | N-PORT |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0.00% | 196,765 SH | Aug. 8, 2026 | Daily |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0.00% | 3,480 SH | Aug. 8, 2026 | Daily |
| DXUV · Dimensional ETF Trust | 0.00% | 4 NS | April 30, 2026 | N-PORT |